Free Trial

Maximus, Inc. (NYSE:MMS) Shares Sold by Thrivent Financial for Lutherans

Maximus logo with Business Services background
Remove Ads

Thrivent Financial for Lutherans decreased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 29.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 14,159 shares of the health services provider's stock after selling 5,789 shares during the period. Thrivent Financial for Lutherans' holdings in Maximus were worth $1,057,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Reinhart Partners LLC. boosted its position in Maximus by 43.5% during the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider's stock worth $41,143,000 after purchasing an additional 167,019 shares during the period. Ruffer LLP purchased a new stake in shares of Maximus in the fourth quarter worth about $10,266,000. Barclays PLC grew its stake in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock valued at $15,927,000 after buying an additional 126,573 shares in the last quarter. Empowered Funds LLC purchased a new stake in shares of Maximus during the 4th quarter valued at about $8,139,000. Finally, Van Berkom & Associates Inc. lifted its position in Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after acquiring an additional 98,264 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd.

Remove Ads

Read Our Latest Research Report on MMS

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Stock Down 1.0 %

Shares of NYSE MMS traded down $0.70 during midday trading on Thursday, reaching $70.33. 504,184 shares of the company's stock were exchanged, compared to its average volume of 538,198. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The business's fifty day moving average price is $69.31 and its two-hundred day moving average price is $77.41. The stock has a market capitalization of $3.98 billion, a PE ratio of 15.12 and a beta of 0.71.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.71%. Maximus's dividend payout ratio (DPR) is 25.81%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads